Syneos Health, Inc. Class A Common Stock
SYNH
SYNH was delisted on the 27th of September, 2023.
317 hedge funds and large institutions have $4.32B invested in Syneos Health, Inc. Class A Common Stock in 2023 Q2 according to their latest regulatory filings, with 82 funds opening new positions, 70 increasing their positions, 125 reducing their positions, and 69 closing their positions.
19% more first-time investments, than exits
New positions opened: 82 | Existing positions closed: 69
17% more capital invested
Capital invested by funds: $3.69B → $4.32B (+$622M)
4% more funds holding
Funds holding: 305 → 317 (+12)
44% less repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 125
46% less call options, than puts
Call options by funds: $2.58M | Put options by funds: $4.79M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$135M |
| 2 |
EIM
Elliott Investment Management
West Palm Beach,
Florida
|
+$133M |
| 3 |
HI
HBK Investments
Dallas,
Texas
|
+$131M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$105M |
| 5 |
GCL
Glazer Capital LLC
New York
|
+$95.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$267M |
| 2 |
EARNEST Partners
Atlanta,
Georgia
|
-$105M |
| 3 |
ClearBridge Investments
New York
|
-$104M |
| 4 |
Nomura Holdings
Tokyo,
Japan
|
-$93.7M |
| 5 |
D.E. Shaw & Co
New York
|
-$78.2M |
SYNH Hedge Fund Activity: Q2 2023 in Review
317 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Syneos Health, Inc. Class A Common Stock (SYNH) for Q2 2023, worth a combined $4.32B — up 17% from $3.69B a quarter earlier.
Buyers outnumbered sellers: 82 funds opened new SYNH positions and 69 closed out — a net gain of 13 holders — while 70 added to existing stakes and 125 trimmed.
The largest buyer was UBS O'Connor, opening a new position worth an estimated $135M. The largest seller was Wellington Management Group, exiting entirely with an estimated $267M sold.
- 317 institutional investors held Syneos Health, Inc. Class A Common Stock (SYNH) as of Q2 2023, up from 305 in Q1 2023.
- Funds reported $4.32B of Syneos Health, Inc. Class A Common Stock stock for Q2 2023, up 17% quarter-over-quarter.
- 82 funds opened new Syneos Health, Inc. Class A Common Stock positions in Q2 2023 and 69 closed out, a net change of +13 holders.
- The largest Syneos Health, Inc. Class A Common Stock buyer in Q2 2023 was UBS O'Connor, an estimated $135M added.
- The largest Syneos Health, Inc. Class A Common Stock seller in Q2 2023 was Wellington Management Group, an estimated $267M sold.
Based on aggregated 13F filings for Q2 2023.